Vertex Pharmaceuticals (VRTX) Change in Inventory (2011 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Change in Inventory of $97.7 million for Q1 2026, down 41.53% year-over-year from $167.1 million in Q1 2025, and up 26.23% quarter-over-quarter from $77.4 million in Q4 2025.
Vertex Pharmaceuticals (VRTX) Change in Inventory (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Change in Inventory history runs 16 years deep, the most recent figure standing at $97.7 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 41.53% year-over-year to $97.7 million; the TTM figure through Mar 2026 stood at $454.8 million (down 24.74% YoY), while the FY2025 annual figure was $524.2 million, up 1.33% from the prior year.
- Change in Inventory for Q1 2026 stood at $97.7 million, up from $77.4 million in the prior quarter.
- The five-year high for Change in Inventory was $182.5 million in Q3 2024, with the low at -$2.0 million in Q1 2022.
- The 5-year median for Change in Inventory is $82.6 million (2023), against an average of $94.0 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory plunged 108.77% in 2022, then jumped 4230.0% in 2023.
- Vertex Pharmaceuticals' Change in Inventory stood at $78.3 million in 2022, then slipped by 10.6% to $70.0 million in 2023, then surged by 110.71% to $147.5 million in 2024, then slumped by 47.53% to $77.4 million in 2025, then grew by 26.23% to $97.7 million in 2026.
- Business Quant data shows VRTX's Change in Inventory at $97.7 million in Q1 2026, $77.4 million in Q4 2025, and $131.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.70 Mn |
| Jun 30, 2026 | 27.70 Mn |
| Mar 31, 2026 | 97.70 Mn |
| Mar 31, 2026 | 97.70 Mn |
| Dec 31, 2025 | 77.40 Mn |
| Dec 31, 2025 | 77.40 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Jun 30, 2025 | 148.60 Mn |
| Jun 30, 2025 | 148.60 Mn |
| Mar 31, 2025 | 167.10 Mn |
| Mar 31, 2025 | 167.10 Mn |
| Dec 31, 2024 | 147.50 Mn |
| Dec 31, 2024 | 147.50 Mn |
| Sep 30, 2024 | 182.50 Mn |
| Sep 30, 2024 | 182.50 Mn |
| Jun 30, 2024 | 107.20 Mn |
| Jun 30, 2024 | 107.20 Mn |
| Mar 31, 2024 | 80.10 Mn |
| Mar 31, 2024 | 80.10 Mn |